Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects

NCT02202473 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Lamivudine
DRUG: Lamivudine+Oxymatrine Capsules

Sponsor

Southeast University, China

Collaborators

[object Object]